Impact of COVID-19 Era on the Anterior Cruciate Ligament Injury Rehabilitation: A Scoping Review.
Nicola MarottaAlessandro de SireDario CalafioreFrancesco AgostiniLorenzo LippiClaudio CurciFrancesco FerraroAndrea BernettiMarco InvernizziAntonio AmmendoliaPublished in: Journal of clinical medicine (2023)
The surgical intervention rate and the subsequent rehabilitation plan for anterior cruciate ligament (ACL) injury was crucially affected by the COVID-19 pandemic due to the necessity in the face of the emergency. This review aimed to evaluate potential persistent and residual symptoms after COVID-19 disease, including fatigue and neuromuscular disorders. A scoping review design and methodology were used due to the exploratory nature of the research question, according to literature searches on PubMed/Medline, Scopus, Web of Science (WoS), and Physiotherapy Evidence Database (PEDro) electronic databases using the following keywords: "Anterior Cruciate Ligament", "ACL", "SARS-CoV-2", and "COVID-19". Undertraining and muscular knee imbalance might cause inefficient movement strategies, lack of knee stability, and increasing load with negative implications in ACL injuries. In the post-surgery period, during COVID-19, telerehabilitation approaches appeared to be successfully applied to maintain strength and range of motion in this condition. However, no definitive data are available regarding the most effective interventions. This scoping review showed the influence of the COVID-19 pandemic and associated restrictions on postoperative and rehabilitative care of ACL injuries.
Keyphrases
- anterior cruciate ligament
- sars cov
- coronavirus disease
- respiratory syndrome coronavirus
- public health
- healthcare
- minimally invasive
- randomized controlled trial
- systematic review
- emergency department
- coronary artery bypass
- palliative care
- sleep quality
- electronic health record
- radiation therapy
- coronary artery disease
- acute coronary syndrome
- pain management
- deep learning
- high intensity
- climate change
- mass spectrometry
- risk assessment
- human health